CEEON UV-ABSORBING SILICONE LENS 920 UNK

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,07 report with the FDA on 1996-10-18 for CEEON UV-ABSORBING SILICONE LENS 920 UNK manufactured by Pharmacia Iovision, Inc..

Event Text Entries

[7765317] An investigation of batch records showed that all release criteria were met. Manufacturer conclusion: no product defect found. No further information is expected.
Patient Sequence No: 1, Text Type: N, H10


[17110301] "the lens split once inside the pt's eye". No other details were provided. In follow-up with the initial reporter, the lens remain "in situ" and the crack occurred in the haptic not in the visual field. The surgeon did not wish to provide any add'l info.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2083358-1996-00004
MDR Report Key44810
Report Source01,05,07
Date Received1996-10-18
Date of Report1996-10-18
Date Mfgr Received1996-10-16
Date Added to Maude1996-10-29
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCEEON UV-ABSORBING SILICONE LENS
Generic NameINTRAOCULAR LENS
Product CodeHOL
Date Received1996-10-18
Model Number920
Catalog NumberUNK
Lot NumberUNK
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Age*
Device Eval'ed by MfgrR
Implant FlagY
Date RemovedA
Device Sequence No1
Device Event Key45720
ManufacturerPHARMACIA IOVISION, INC.
Manufacturer Address15350 BARRANCA PKWY IRVINE CA 92718 US
Baseline Brand NameCEEON
Baseline Generic NameINTRAOCULAR LENS
Baseline Model No920
Baseline Catalog NoNA
Baseline IDWS127
Baseline Device FamilyPLIOLENS, MODEL WS100
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]48
Baseline PMA FlagY
Premarket ApprovalP9400
Baseline 510K PMNN
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
10 1996-10-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.